Vishakh C Keri

10PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical biochemistry - lipidsPredictive and prognostic markersOne health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2024
Infections following chimeric antigen receptor T cell therapy: 2018-2022.

Vishakh C Keri, Lea M Monday, Jahanavi M Ramakrishna

|Jan 30, 2024
False-Positive Human Immunodeficiency Virus Nucleic Acid Amplification Test After Chimeric Antigen Receptor T-Cell Therapy With Ciltacabtagene Autoleucel.

Vishakh C Keri, Mary Vito Topulli, Abhinav Deol

|Mar 09, 2023
Mitochondrial toxicity induced by linezolid causing lactic acidosis.

Kunal Sharma, Vishakh C Keri, Tirlangi Praveen Kumar

|Aug 15, 2022
Clinical profile of ChAdOx1 nCoV-19- and BBV152-vaccinated individuals among hospitalized COVID-19 patients: a pair-matched study.

Vishakh C Keri, Bharathi Arunan, Parul Kodan

|Apr 07, 2021
Decentralizing COVID-19 care-Moving towards a COVID-19-capable healthcare system (CCHS).

Vishakh C Keri, R L Brunda, Pankaj Jorwal

|Oct 31, 2020
Intricate interplay between Covid-19 and cardiovascular diseases.

Vishakh C Keri, Amit Hooda, Parul Kodan

Pageof 2

Frequent Collaborators

4 joint publications

R L Brunda

2 joint publications

Pankaj Jorwal

1 joint publications

Tirlangi Praveen Kumar